by TractManager | Oct 20, 2016 | Precision Therapy Assessment
Purpose of Technology: Sofosbuvir-velpatasvir (Epclusa) is a “next-generation” once-daily direct-acting antiretroviral (DAA) combination oral regimen for the treatment of all 6 major hepatitis C virus (HCV) genotypes. The fixed-dose combination pill contains 400 mg of...
by TractManager | Oct 20, 2016 | Health Technology Assessment
Purpose of Technology: Following breast-conserving surgery in patients with early-stage breast cancer, accelerated partial breast irradiation (APBI) is an alternative to standard whole-breast irradiation (WBI) performed to reduce the risk of tumor recurrence. APBI...
by TractManager | Oct 6, 2016 | Health Technology Assessment
Purpose of Technology: Extracorporeal shock wave therapy (ESWT) is a noninvasive treatment for chronic plantar fasciitis that involves delivery of shock waves to the painful region of the heel with the goal of reducing pain, increasing function, and promoting healing...
by TractManager | Oct 6, 2016 | Health Technology Assessment
Purpose of Technology: The measurement of nitric oxide (NO) concentration in expired breath has been introduced as an adjunct to or replacement for the established clinical and laboratory assessments for the diagnosis of asthma. Measurement of fractional exhaled...
by TractManager | Oct 4, 2016 | Emerging Technology Report
An intravenous antidote proposed for new oral anticoagulants.If you have a Hayes login, click here to view the full report on the Knowledge Center.
Recent Comments